Riqiclav-625 Tablets

Riqiclav-625 Tablets is a combination of Amoxycillin 500 mg and Potassium Clavulanate 125 mg, formulated to treat a broad range of susceptible bacterial infections. Amoxycillin provides effective antibacterial action, while Clavulanic Acid enhances its activity by protecting it from beta-lactamase-producing bacteria. It is commonly prescribed for infections of the respiratory tract, ear, nose and throat, urinary tract, skin, soft tissues, bones, joints, and dental infections. The convenient film-coated tablet offers effective oral antibacterial therapy and should be used only under the guidance of a qualified healthcare professional.

Category:

Description

Amoxycillin & Potassium Clavulanate Tablets I.P.

Riqiclav-625 Tablets is a combination antibiotic containing Amoxycillin and Potassium Clavulanate, formulated to treat a wide range of bacterial infections caused by susceptible microorganisms. Amoxycillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Clavulanic Acid acts as a beta-lactamase inhibitor, protecting Amoxycillin from bacterial enzymes that can cause antibiotic resistance. This combination extends the antibacterial spectrum and enhances treatment effectiveness against resistant bacteria.

Riqiclav-625 Tablets are commonly prescribed for infections of the respiratory tract, ear, nose and throat, urinary tract, skin and soft tissues, dental infections, and bone and joint infections. The dual-action formulation provides reliable antibacterial coverage and helps achieve effective infection control when used as prescribed by a healthcare professional. To ensure the best clinical outcome and help reduce the risk of antibiotic resistance, the complete prescribed course should always be finished.

Key Benefits

  • Broad-spectrum antibacterial activity.
  • Effective against beta-lactamase-producing bacteria.
  • Helps manage a wide range of bacterial infections.
  • Dual-action formulation for enhanced antibacterial efficacy.
  • Suitable for respiratory, urinary, ENT, skin, soft tissue, and dental infections.
  • Film-coated tablets for convenient oral administration.
  • Intended for use under the supervision of a qualified healthcare professional.

Composition

Each film-coated tablet contains:

  • Amoxycillin Trihydrate IP equivalent to Amoxycillin 500 mg
  • Potassium Clavulanate IP equivalent to Clavulanic Acid 125 mg

Indications

Recommended for the treatment of susceptible bacterial infections, including:

  • Upper and lower respiratory tract infections
  • Ear, nose, and throat infections
  • Acute bacterial sinusitis
  • Urinary tract infections
  • Skin and soft tissue infections
  • Dental infections
  • Bone and joint infections

Directions for Use

Take the tablet exactly as prescribed by the physician, preferably at the beginning of a meal to improve absorption and reduce stomach discomfort. Swallow the tablet whole with water and complete the full course of treatment, even if symptoms improve before the course is finished.

Storage

  • Store below 25°C in a cool and dry place.
  • Protect from moisture and direct sunlight.
  • Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “Riqiclav-625 Tablets”

Your email address will not be published. Required fields are marked *